Fairvalue-Calculator Fairvalue-Calculator
EN DE

Merchavia Holdings (MRHL) Fair Value & Analysis

Healthcare · Il · Market cap 38.0M ILA

Price1.72 ILA
Fair Value0.4900 ILA
Upside-71.5%
Quality95/100
Evidence: Low Range 0.3700 ILA – 0.7300 ILA

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Merchavia Holdings (MRHL) currently trades at 1.72 ILA, while our model-based Fair Value estimate is 0.4900 ILA — implying the stock looks roughly 71.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Merchavia Holdings and Investments Ltd is a principal investment firm. The firm prefers to invest in companies doing business in technology, med-tech, medicine, medical products, medical solutions and medical distribution related sectors. It prefers to invest in companies related to Cleveland Clinic. Merchavia Holdings and Investments Ltd was founded in 1972 and is based in Bnei Brak, Israel with additional office in Bnei Brak, Israel.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -73% Fresenius SE (FSNUY) -27% 5225 (5225) -70% IHHHF (IHHHF) -26% Rede D'Or São Luiz S.A (RDOR3) -7% Tenet Healthcare Corporation (THC) +74%

Frequently asked questions

Is Merchavia Holdings (MRHL) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 0.4900 ILA versus a price of 1.72 ILA — about −72% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MRHL?
Our 21-model fair value for Merchavia Holdings is 0.4900 ILA (as of Jun 26, 2026), built from audited fundamentals. The current price is 1.72 ILA.
What is the quality score of MRHL?
Merchavia Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.